Under the agreement terms, Arvinas will leverage the Gemini Virtual Patient models of GNS to gain better understanding of the biology of the underlying disease. Arvinas will understand
The post GNS and Arvinas partner for neurodegenerative disease drug development appeared first on Pharmaceutical Business review.